Int. Journal of Drug cGMP
Locum International Press.
Issues #1 - # 8.
Eight issues /year.
The International Journal of Drug cGMP -
US Edition is targeted to the US geographic zones (Firms who require to
understand current US GMP).
When the FDA knocks on your door for a GMP or PAI inspection - you will
be glad you subscribed. Learn about the problems and prospects in the
regulatory environment and receive practical advise on compliance from
top industry experts.
The journal publishes articles, reviews and
papers on all aspects of Generic and Innovative Drug cGMP. Emphasis is
places on current Good Clinical, Development, Validation, Manufacture,
Laboratory and Documentation Practices.
The US Journal highlights cGMP exposure of the Drug Industry with special
reference to the on-time development of NDA
and ANDA submissions. Similar concepts
are valid for the EU and PR editions.
aspects of pharmaceutical Good Practices covering practical hands-on nuts-and-
bolts issues that vary across the full drug spectrum, including excipients
development (pre-to-final) formulation, scale-up, analytical, cleaning
and process validation necessary for the entire
drug manufacture and control process to meet the agencies expectations.
The overall objective in cGMP is to maintain the current drug profile
in the market place avoiding warning letters and negative PAI
The Journal attempts to clarify and simplify laboratory, manufacturing
and control GMP, GLP, GDP, GVP and GRP issues to achieve this crucial
80 - 95 pp
illustrated b/w &
Subscription - Print
$1499.00 - Print Edition (single-user airmail print edition worldwide)
$1699.00 - Corporate single license single pharma campus - (Print / CD)
$1999.00 - Corporate multiple-user license - (print edition maximizes
distribution and readership for multiple pharma campus)
QUICK ORDER PROCESS
Print format are ordered direct from Locum International
Publishers by e-mail